{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T19:49:40Z","timestamp":1673034580457},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1245\/s10434-014-4193-5","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T15:10:43Z","timestamp":1414768243000},"page":"1974-1979","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk Factors for the Development of Uterine Cancer in Breast Cancer Survivors: An Army of Women Study"],"prefix":"10.1245","volume":"22","author":[{"given":"Diogo","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah W.","family":"Eshraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth C.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela T.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Milam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"4193_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma\u00a0J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29. doi: 10.3322\/caac.21208 .","journal-title":"CA Cancer J Clin."},{"key":"4193_CR2","doi-asserted-by":"crossref","unstructured":"Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women\u2019s Health Initiative (United States). Cancer Causes Control 2002;13:741\u201351. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12420953 . Accessed 2 July 2014.","DOI":"10.1023\/A:1020239211145"},{"key":"4193_CR3","doi-asserted-by":"crossref","unstructured":"Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women\u2019s health initiative randomized trial. 2003;3243\u20133253. doi: 10.1001\/jama.289.24.3243 .","DOI":"10.1001\/jama.289.24.3243"},{"key":"4193_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bjc.1988.44","volume":"57","author":"TJ Key","year":"1988","unstructured":"Key TJ, Pike MC. The dose-effect relationship between \u201cunopposed\u201d oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer. 1988;57:205-12.","journal-title":"Br J Cancer."},{"key":"4193_CR5","doi-asserted-by":"crossref","unstructured":"Fisher B, Costantino J. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Natl Cancer. 1994;86:527\u201337. http:\/\/jnci.oxfordjournals.org\/content\/86\/7\/527.short . Accessed 2 July 2014.","DOI":"10.1093\/jnci\/86.7.527"},{"key":"4193_CR6","doi-asserted-by":"crossref","unstructured":"Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. 1998;1371\u201388. doi: 10.1093\/jnci\/90.18.1371 .","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"4193_CR7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2008.08.035","volume":"112","author":"AE Bland","year":"2009","unstructured":"Bland AE, Calingaert B, Secord AA, et al. Relationship between tamoxifen use and high risk endometrial cancer histologic types. Gynecol Oncol. 2009;112:150-4. doi: 10.1016\/j.ygyno.2008.08.035 .","journal-title":"Gynecol Oncol."},{"key":"4193_CR8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2005.10.026","volume":"101","author":"SE Ferguson","year":"2006","unstructured":"Ferguson SE, Soslow RA, Amsterdam A, Barakat RR. Comparison of uterine malignancies that develop during and following tamoxifen therapy. Gynecol Oncol. 2006;101:322-6. doi: 10.1016\/j.ygyno.2005.10.026 .","journal-title":"Gynecol Oncol."},{"key":"4193_CR9","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/bcr3206","volume":"14","author":"ME Jones","year":"2012","unstructured":"Jones ME, van Leeuwen FE, Hoogendoorn WE, et al. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Breast Cancer Res. 2012;14:R91. doi: 10.1186\/bcr3206 .","journal-title":"Breast Cancer Res."},{"key":"4193_CR10","unstructured":"Miyoshi Y, Funahashi T, Kihara S, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res. 2003;9:5699\u2013704. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14654554 . Accessed 2 July 2014."},{"key":"4193_CR11","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1530\/EC-13-0061","volume":"2","author":"N Cinar","year":"2013","unstructured":"Cinar N, Gurlek A. Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: An experimental and clinical update. Endocr Connect. 2013;2:R30-8. doi: 10.1530\/EC-13-0061 .","journal-title":"Endocr Connect."},{"key":"4193_CR12","author":"E Seven","year":"2014","unstructured":"Seven E, Husemoen LLN, Wachtell K, Ibsen H, Linneberg A, Jeppesen JL. Overweight, adipocytokines and hypertension: a prospective population-based study. J Hypertens. 2014. doi: 10.1097\/HJH.0000000000000207 .","journal-title":"J Hypertens."},{"key":"4193_CR13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2362.2006.01611.x","volume":"36","author":"SN Wang","year":"2006","unstructured":"Wang SN, Yeh YT, Yu ML, et al. Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease. Eur J Clin Invest. 2006;36:176-80. doi: 10.1111\/j.1365-2362.2006.01611.x .","journal-title":"Eur J Clin Invest."},{"key":"4193_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2010.07.007","volume":"119","author":"N Ashizawa","year":"2010","unstructured":"Ashizawa N, Yahata T, Quan J, Adachi S, Yoshihara K, Tanaka K. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol. 2010;119:65-9. doi: 10.1016\/j.ygyno.2010.07.007 .","journal-title":"Gynecol Oncol."},{"key":"4193_CR15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2478\/v10039-009-0035-2","volume":"54","author":"M Gnaci\u0144ska","year":"2009","unstructured":"Gnaci\u0144ska M, Ma\u0142gorzewicz S, Stojek M, \u0141ysiak-Szyd\u0142owska W, Sworczak K. Role of adipokines in complications related to obesity: a review. Adv Med Sci. 2009;54:150-7. doi: 10.2478\/v10039-009-0035-2 .","journal-title":"Adv Med Sci."},{"key":"4193_CR16","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2006-2614","volume":"92","author":"AJG Hanley","year":"2007","unstructured":"Hanley AJG, Bowden D, Wagenknecht LE, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab. 2007;92:2665-71. doi: 10.1210\/jc.2006-2614 .","journal-title":"J Clin Endocrinol Metab."},{"key":"4193_CR17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10\u00a0years versus stopping at 5\u00a0years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381:805-16. doi: 10.1016\/S0140-6736(12)61963-1 .","journal-title":"Lancet."},{"key":"4193_CR18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer. 1994;73:643-51. doi: 10.1097\/00006254-199406000-00016 .","journal-title":"Cancer."},{"key":"4193_CR19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-86. doi: 10.1093\/jnci\/81.24.1879 .","journal-title":"J Natl Cancer Inst."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4193-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4193-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4193-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T21:46:37Z","timestamp":1565991997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4193-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["4193"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4193-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,1]]}}}